13
Participants
Start Date
March 31, 2014
Primary Completion Date
August 31, 2014
Study Completion Date
AZD5069
oral BD administration of 45 mg AZD5069
Research Site, Großhansdorf
Lead Sponsor
AstraZeneca
INDUSTRY